Is "Nature's Ozempic" Real? Berberine and Other Claims, Fact-Checked

No. Nothing marketed as a “nature’s Ozempic” has been shown to work like Ozempic, and health experts who have reviewed these products say none comes close. The phrase got attached to berberine through social media and TikTok, where some posters claim it helps people lose weight the same way Ozempic does ^[3][4]. The Department of Defense’s Operation Supplement Safety (OPSS) reviewed the evidence and concluded plainly: “The evidence does not support claims for berberine as the ‘key to weight loss,’” and claims that berberine is “Nature’s Ozempic” are exaggerated and not supported by the evidence ^[3]. C. Michael White, a professor of pharmacy practice at the University of Connecticut School of Pharmacy, puts it the same way: marketing that suggests natural products can give you the same effect as GLP-1 agonist medications “is simply not the case” ^[6].

The gap between the claims and the evidence is large enough to measure. In a 72-week head-to-head trial, people taking Wegovy (semaglutide) lost an average of 33.1 lbs (15.0 kg), while people taking Zepbound (tirzepatide) lost an average of 50.3 lbs (22.8 kg) ^[1]. In a meta-analysis of berberine trials, body weight did not change significantly at all ^[2]. Below is what each popular “natural Ozempic” claim actually rests on.

How much weight do people lose on a real GLP-1 drug?

The clearest yardstick comes from SURMOUNT-5, a Phase 3b open-label trial that ran for 72 weeks, randomized 751 adults across the U.S. and Puerto Rico, and compared Zepbound head-to-head against Wegovy in adults with obesity, or overweight with at least one weight-related medical problem, who did not have diabetes (registered as NCT05822830) ^[1]. The results were presented at the 32nd European Congress on Obesity, published in The New England Journal of Medicine, and announced on May 11, 2025 ^[1].

At 72 weeks, participants on Wegovy — a mono GLP-1 receptor agonist — achieved an average weight reduction of 13.7%, or 33.1 lbs (15.0 kg). Participants on Zepbound — a dual GIP and GLP-1 receptor agonist — achieved an average reduction of 20.2%, or 50.3 lbs (22.8 kg) ^[1].

Measure at 72 weeks	Wegovy (semaglutide)	Zepbound (tirzepatide)
Average weight loss	13.7%	20.2%
Average pounds lost	33.1 lbs (15.0 kg)	50.3 lbs (22.8 kg)
Achieved ≥15% weight loss	40.1%	64.6%
Waist circumference reduction	−13.0 cm	−18.4 cm

Adverse events in the trial were mainly gastrointestinal and generally mild to moderate ^[1]. During the trial, 8.0% of participants taking Wegovy discontinued treatment due to adverse events, compared with 6.1% taking Zepbound — though the study was not powered to compare the safety and tolerability of the two drugs ^[1]. That is the scale of effect a real GLP-1 medication delivers under trial conditions — and it is the number any “natural” alternative is implicitly claiming to match. As White put it, supplements do not produce “the 20-something-pound weight loss that you actually get with a real GLP-1 agonist” ^[6].

Does berberine work like Ozempic?

No. Berberine does not mimic the GLP-1 hormone, and the trials do not show Ozempic-like weight loss.

Mechanistically, the two work differently. GLP-1 drugs mimic the GLP-1 hormone the body produces naturally, which helps regulate appetite and digestion ^[4][6]. Berberine instead activates an enzyme called AMPK (adenosine monophosphate-activated protein kinase), which affects metabolism and energy use. Activating that enzyme may increase fat burning and reduce fat storage, and berberine may also enhance brown adipose tissue, a type of body fat involved in calorie burning ^[4]. That is a different pathway from what Ozempic does, which is one reason the “nature’s Ozempic” framing misleads.

The weight evidence itself is thin. A 2020 dose-response meta-analysis of ten randomized controlled trials found that berberine supplementation was associated with a small reduction in body mass index (WMD −0.29 kg/m², 95% CI −0.51 to −0.08, p = 0.006) and waist circumference (WMD −2.75 cm, 95% CI −4.88 to −0.62, p = 0.01) — but no significant change in body weight at all (WMD −0.11 kg, 95% CI −0.99 to 0.76, p = 0.79) ^[2].

OPSS looked at the berberine weight-loss research and reached a similar bottom line. One review reported a weight reduction of 0.84 kg (almost 2 lbs) in people with certain diseases, over up to 18 weeks of use — but when low-quality studies were excluded, that reported weight reduction “no longer exists” ^[3]. OPSS notes the studies were mostly small and conducted in non-U.S. populations with existing diseases, and that their quality means the results cannot be used to inform use ^[3].

A meta-analysis by the European Society for Clinical Nutrition and Metabolism, cited by PBS NewsHour, found patients taking berberine lose a little over 4 pounds on average ^[6]. Other supplement ingredients used in GLP-1-branded products help with between 1 and 3 pounds, according to White ^[6]. UCLA Health’s summary is that the amount of weight a person can lose with berberine is unclear and the evidence is inconclusive; in studies where participants saw a reduced BMI and waistline, they took 1 gram of berberine daily, and effects appeared after at least eight weeks of use ^[4]. That 1 gram figure describes what researchers studied, not a recommended dose.

The American Academy of Family Physicians has covered the trend with the headline that the berberine fad “Lacks Rigorous Evidence, Has Potential Harms” ^[5].

Where does berberine actually have some evidence?

Berberine’s stronger research is in blood sugar and lipids, not weight — and even that evidence has quality problems.

Berberine is a plant alkaloid found in the roots, stems and bark of plants including barberry, tree turmeric, Oregon grape and goldenseal ^[3]. A very small pilot study from 2008 found equivalent glucose lowering with berberine versus metformin in people with type 2 diabetes ^[5]. A 2018 systematic review of randomized controlled trials comparing berberine to placebo or approved prescription hypoglycemic medications found berberine superior on fasting and/or postprandial glucose levels — but the included trials were deemed of “low to moderate” quality ^[5].

There has never been a large-scale, randomized, multicenter clinical trial of the kind new diabetes drugs must undergo to obtain FDA approval ^[5]. So none of this adds up to FDA-recognized efficacy; it is early, mixed-quality research.

On lipids, the picture is somewhat better. Studies show berberine significantly lowers triglycerides, and it has been found to improve LDL and HDL cholesterol levels in people whose levels are abnormal ^[4].

Is berberine safe?

Berberine is not banned — it is not on the DoD Prohibited Dietary Supplement Ingredients List — but it is not risk-free either ^[3].

The most common side effects reported in adults are diarrhea, constipation, nausea and stomach upset ^[3][4]. Headaches have also been reported ^[4]. The safety of long-term use is unknown ^[3].

The interaction risks are real. Berberine has known interactions with medications metabolized by the liver, including metformin ^[5]. It may interact with anti-rejection drugs taken after an organ transplant, and if a person is already taking diabetes medication, berberine could make that drug more potent ^[4].

Berberine should not be taken by anyone who is pregnant, nursing, or planning to become pregnant: it can cause a buildup of bilirubin that can be harmful to infants ^[3][4]. There is not enough information to know whether berberine is safe for children ^[3].

Two product-level concerns add risk. It is impossible to know for sure whether the ingredients listed on the bottle accurately represent what is inside the bottle ^[5]. And weight-loss products in general sometimes contain hidden drugs or other potentially harmful ingredients, so OPSS advises checking whether a product has been evaluated by an independent, third-party organization ^[3].

Is yerba mate a natural GLP-1?

No. Yerba mate has an interesting research base, but it is mostly cells and animals, and nothing in it approaches GLP-1-drug weight loss.

A 2015 review in the journal Nutrients examined yerba maté (Ilex paraguariensis) in obesity ^[7]. Cellular studies show it suppresses adipocyte differentiation and triglyceride accumulation and reduces inflammation. Animal studies show it modulates signaling pathways that regulate adipogenesis, antioxidant responses, anti-inflammatory responses and insulin signaling ^[7].

The review’s own conclusion is hedged: yerba maté “might be useful” against obesity and may improve lipid parameters in humans and animal models ^[7]. “Might be helpful” is the language of early research, not of a drug equivalent. The review contains no human trial showing weight loss anywhere near what a GLP-1 medication produces ^[7].

Does apple cider vinegar work for weight loss?

The one peer-reviewed paper that seemed to show impressive weight loss from a few spoonfuls of apple cider vinegar a day no longer stands. It has been retracted due to flaws that make its results untrustworthy, as a commentary from McGill University’s Office for Science and Society, published October 8, 2025, explained ^[8]. The retraction has also been reported by BMJ Group and NPR ^[9][10]. A retracted paper is not evidence of anything, so the claim that a few spoonfuls of vinegar a day produces meaningful weight loss currently rests on a withdrawn study.

Do GLP-1 patches and other “GLP-1” products sold online actually deliver anything?

There is no evidence they deliver anything close to a GLP-1 drug, and some do not even tell you what is in them.

Supplement makers have flooded the market with pills, powders, drops and patches bearing “GLP-1” branding ^[6]. One patch product marketed as “GLP-1 Patches” claims to “support healthy weight management and appetite control” and says it increases production of glucagon-like peptide-1 after two months of use ^[6].

The category breaks into three types, according to PBS NewsHour’s reporting: supplements claiming to replace GLP-1 agonists completely, “natural” versions that may work but be substantially less effective, and products meant to be taken alongside a prescription to “boost” GLP-1 production ^[6]. None of these are remotely as effective as semaglutide or tirzepatide, experts told PBS ^[6].

A brand agency that wanted a TikTok influencer to promote GLP-1 patches advised her against using the words “Ozempic,” “weight loss,” “blood sugar” and “GLP-1” in her promotional content — and when she asked whether the product was FDA approved, the agency never responded ^[6]. White notes that some of these products do not disclose their ingredients at all, and buyers may believe they are getting semaglutide or tirzepatide ^[6].

Bryn Austin, professor of social and behavioral sciences at the Harvard T.H. Chan School of Public Health, calls the “GLP-1” naming deceptive: any consumer who sees it will think, “Oh, it must work like Ozempic” ^[6].

Why do these products exist at all?

Two forces created this market: a big cost gap and a regulatory framework that does not require proof.

On the cost side, Wegovy and Zepbound are typically injected once a week, cost hundreds of dollars a month out of pocket, and are often not covered by insurance ^[6]. Semaglutide’s cost and intermittent drug shortages have made it difficult for many people to access ^[5]. That leaves a hole in the consumer market that supplement companies moved to fill ^[6].

On the regulatory side, in 1994 Congress passed the Dietary Supplement Health and Education Act, which defined dietary supplements and created a framework that largely bypasses the FDA ^[6]. Unlike drugs, supplement manufacturers are generally not required to provide safety evidence before releasing a product, with some exceptions; manufacturers and distributors hold the initial responsibility for ensuring their supplements meet safety standards ^[6]. The FDA “does NOT have the authority to approve dietary supplements for safety and effectiveness” ^[5].

Jensen Jose, regulatory counsel for the Center for Science in the Public Interest, describes the practical result: companies have to tell the FDA that they have evidence, but they do not have to provide it ^[6]. Austin adds that the FDA cannot require pre-screening for effectiveness because, by law, supplements cannot claim to treat, cure or prevent disease — even though the marketing on packages leads consumers to infer exactly that ^[6].

There is also a safety history to know about. Compared with other supplement categories, products marketed for weight loss have a long history of being adulterated, sometimes including extreme levels of stimulants ^[6].

Can a supplement replace a prescription GLP-1 if I can’t afford the drug?

The evidence says no supplement comes close. A meta-analysis by the European Society for Clinical Nutrition and Metabolism found a little over 4 pounds of average loss with berberine ^[6]; the pooled trials in another meta-analysis showed no significant body-weight change at all ^[2]; other ingredients run 1 to 3 pounds ^[6]. Wegovy produced 33.1 lbs of average loss at 72 weeks in SURMOUNT-5 ^[1]. Those are different categories of effect, not different prices for the same result.

Decisions about a prescription medication — including whether to stop, switch or substitute anything for it — belong with a clinician. Dana Ellis Hunnes, the senior clinical dietitian quoted in the UCLA Health article, recommends speaking with a primary care physician or a pharmacist before taking berberine, and also talking with a dietitian ^[4]. OPSS likewise advises speaking with a qualified healthcare provider before taking any dietary supplement ^[3].

How can I sanity-check any “natural Ozempic” product before buying?

A few checks separate the marketing from the evidence:

• Is there a randomized trial of the finished product? Ask whether a randomized trial exists for the product itself, and whether the dose on the label matches what the cited study used ^[3][5]. Berberine has never been through the large-scale, randomized, multicenter trials required for FDA drug approval ^[5].
• Is the outcome actual weight, or just a biomarker? The berberine meta-analysis is a cautionary example: it moved BMI and waist circumference but found no significant change in body weight ^[2]. A product can cite “improved markers” while the scale does not move.
• Is there third-party testing? Look for a label showing the product has been evaluated by an independent, third-party organization, since weight-loss products sometimes contain hidden drugs ^[3].
• Have you talked to a professional? Speak with a healthcare provider, pharmacist or dietitian before starting any supplement, particularly if you take prescription medications ^[3][4].

The pattern across every “nature’s Ozempic” claim is the same: a real mechanism difference from GLP-1 drugs, small or null trial results, and marketing that borrows a drug’s reputation without its evidence.

Sources

1. Eli Lilly and Company. Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine. May 11, 2025.
2. Complementary Therapies in Clinical Practice. The effect of berberine supplementation on obesity indices: A dose-response meta-analysis and systematic review of randomized controlled trials. May 2020.
3. OPSS. Berberine: The hype for “Nature’s Ozempic”.
4. UCLA Health. What to know about berberine, the so-called “nature’s Ozempic”. October 22, 2025.
5. American Academy of Family Physicians. Weight loss fad berberine (“Nature’s Ozempic”) lacks rigorous evidence, has potential harms. July 3, 2023.
6. PBS News. In the gray world of GLP-1 supplements online, health experts urge caution.
7. PMC. The positive effects of yerba maté (Ilex paraguariensis) in obesity.
8. McGill University Office for Science and Society. Apple cider vinegar…again.
9. BMJ Group. BMJ Group retracts trial on apple cider vinegar and weight loss.
10. NPR. How apple cider vinegar cured everything — until it didn’t. October 5, 2025.
11. PMC. Effect of apple cider vinegar intake on body composition in humans with type 2 diabetes and/or overweight: A systematic review and meta-analysis of randomized controlled trials.
12. Mayo Clinic. Apple cider vinegar for weight loss. March 4, 2025.
13. PMC. Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: A comprehensive review and meta-analysis.
14. The Journal of Nutrition. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. April 2010.
15. Nature Medicine. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. July 2019.
16. Nature Medicine. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: A controlled randomized trial. June 2026.
17. SupplySide Supplement Journal. Regulators mostly silent on GLP-1 supplement claims.
18. Obesity. A systematic review of dietary supplements and alternative therapies for weight loss. July 2021.
19. Science Media Centre. Expert reaction to an RCT on the use of pasteurized Akkermansia muciniphila MucT for weight loss maintenance after an 8-week low-energy diet. May 12, 2026.
20. Federal Trade Commission. Press release on weight loss patch manufacturer banned from selling weight loss patches. August 2007.
21. US Food and Drug Administration. FDA Roundup: December 17, 2024. December 17, 2024.
22. PubMed. Once-weekly semaglutide in adults with overweight or obesity.
23. Obesity. A systematic review of dietary supplements and alternative therapies for weight loss. 2021.